𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease

✍ Scribed by C. Mytilineou; P. Werner; S. Molinari; A. Di Rocco; G. Cohen; M. D. Yahr

Publisher
Springer
Year
1994
Tongue
English
Weight
424 KB
Volume
8
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Risk factors for Parkinson's disease and
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease
✍ Andrew Siderowf; Danna Jennings; James Connolly; Richard L. Doty; Kenneth Marek; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first‐degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id

A controlled trial of piracetam in intel
A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease
✍ Mary Sano; Yaakov Stern; Karen Marder; Richard Mayeux πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 428 KB πŸ‘ 1 views

## Abstract Twenty patients with Parkinson's disease and marked intellectual impairment or dementia participated in a double‐blind placebo controlled trial of the nootropic, piracetam. A standardized neurological examination, a neuropsychological test battery, and a functional scale, The Sickness I